Plum SEC
Menu
Korean Stock
Company Information
Customer Service
Korean Stock
FSS DART Disclosures
PERI
UNISON
★★★★
Unison: Sharp Sales Decline and Continued Operating Loss in Q1 2026
2026-05-15 17:27
PERI
NAMSUNG
☆
Namsung 1Q 2026: Operating Profit Declines, Net Profit Surges on Non-Recurring Gains, Dividend Paid
2026-05-15 17:27
PERI
Polaris Office
★★
Polaris Office 2026 Q1 Earnings Improve, Treasury Shares Canceled - Operating Profit Up, EPS Rises
2026-05-15 17:26
PERI
Orum Therapeutics
☆
Orum Therapeutics Widens Operating Loss in Q1 but Secures 145B Won in Funding
2026-05-15 17:26
PERI
BNC KOREA
★
BNC Korea Posts Q1 2026 Consolidated Net Loss of 1.3B Won, Declares First Cash Dividend of 70 Won per Share
2026-05-15 17:26
PERI
Namuga
★
Namuga 2026 Q1 Results: Revenue Down 30%, Earnings Decline
2026-05-15 17:26
PERI
KMPHARMACEUTICAL
★★
KM Pharmaceutical: Q1 Sales 4.47B Won, Operating Loss 0.66B Won, Stock Consolidation Approved
2026-05-15 17:26
PERI
Sewon
★
Polaris Sewon Q1 2026 OP Rises…Share Consolidation and New Investment
2026-05-15 17:26
PERI
Agent AI
★★
Agent AI Q1 2026: Net loss continues at 2.04 bln won, net debt ratio rises to 41.35%, 20:1 reverse stock split completed
2026-05-15 17:26
PERI
NATURECELL
☆
NatureCell Q1 2026: FDA Breakthrough Therapy Designation for JointStem Continues, Domestic Approval Rejected and Lawsuit Ongoing, Net Loss Narrows
2026-05-15 17:26
← Previous
Next →